Parkinson's disease (PD) is a progressive neurodegenerative disorder that primarily affects dopaminergic neurons in the substantia nigra. It is characterized by motor symptoms such as tremors, rigidity, and bradykinesia, as well as non-motor symptoms including cognitive impairment and mood disorders. This article aims to provide a comprehensive overview of PD for healthcare professionals.
The exact cause of PD remains unknown, but it is thought to involve a combination of genetic and environmental factors. Pathologically, PD is characterized by the loss of dopamine-producing neurons in the substantia nigra and the presence of Lewy bodies, which are protein aggregates primarily composed of alpha-synuclein. This leads to an imbalance in the basal ganglia circuitry, resulting in the characteristic motor symptoms of PD.
The cardinal motor symptoms of PD include resting tremor, rigidity, bradykinesia, and postural instability. Non-motor symptoms such as autonomic dysfunction, cognitive impairment, mood disorders, and sleep disturbances are also common and often precede the onset of motor symptoms. The disease progression is typically asymmetric, with symptoms appearing on one side of the body before the other.
PD is primarily diagnosed based on clinical criteria, with neuroimaging used to rule out other causes of parkinsonism. The management of PD involves a multidisciplinary approach, with pharmacological treatment aimed at managing symptoms and improving quality of life. Levodopa remains the most effective medication for motor symptoms, while non-pharmacological interventions include physical and occupational therapy.
Understanding PD's complexities is crucial for healthcare professionals to provide optimal care. Although there is currently no cure, advances in research continue to shed light on the disease's pathophysiology, potentially paving the way for more effective treatments in the future.
1.
Race, Geography Linked to Gaps in Prostate Cancer Care
2.
Sports for girls are frequently abandoned due to uniform issues.
3.
According to the Lancet, having cancer and VTE at the same time increases mortality risk.
4.
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer
5.
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma
1.
Hematopoietic Clonal Competition in Blood Disorders
2.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
3.
Developmental Iron Biology Beyond Infancy: Mechanisms, Clinical Implications, and Emerging Directions
4.
Next-Generation Bone Marrow Harvest Technologies
5.
Strategic Applications in Hematology in Clinical Decision-Making
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding the Common Causes of Anemia
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation